
    
      The study included 47 men and 29 women, average age around 60 years, with coronary
      atherosclerosis diagnosed by angiography. Data from patients were obtained at beginning and
      after four months of treatment with 10 mg rosuvastatin, concomitantly with zinc (30mg/d) and
      selenium (150Î¼g/d) supplementation or placebo. The anthropometric and dietary data, zinc and
      selenium concentrations in plasma and erythrocyte, lipid profile, electronegative LDL
      (LDL(-)), anti- electronegative LDL, Ac-LDL(-) immune complexes, GPx and SOD activities, IL-6
      and hs-CRP were evaluated in all patients.
    
  